Propane

Propane

SCHEMBL480215

CCC.CCCCCCCC/C=C\CCCCCCCC(=O)[N+](C)(C)C(=O)CCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 6/20 0.62
TERT O14746 3/20 0.61
PTPN1 P18031 3/20 0.61
PPARG P37231 3/20 0.61
PPARD Q03181 3/20 0.61
PPARA Q07869 3/20 0.61
CYP1A2 P05177 2/20 0.61
MAPT P10636 2/20 0.61
CYP2C19 P33261 2/20 0.61
BLM P54132 2/20 0.61
HSD17B10 Q99714 2/20 0.61
FABP4 P15090 2/20 0.61
FAAH O00519 2/20 0.61
KMT2A Q03164 2/20 0.61
F7 P08709 2/20 0.61
F3 P13726 2/20 0.61
GMNN O75496 1/20 0.61
USP2 O75604 1/20 0.61
LMNA P02545 1/20 0.61
POLB P06746 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propane SCHEMBL480216 1.00 FABP3 (0.62) FABP3TERTPTPN1PPARGPPARD
SCHEMBL7045888 0.98 FABP3 (0.65) FABP3TERTPTPN1PPARGPPARD
SCHEMBL4133929 0.98 FABP3 (0.65) FABP3TERTPTPN1PPARGPPARD
SCHEMBL1626315 0.98 FABP3 (0.65) FABP3TERTPTPN1PPARGPPARD
Water SCHEMBL3915284 0.96 FABP3 (0.62) FABP3TERTPTPN1PPARGPPARD
Iodide SCHEMBL6695071 0.96 FABP3 (0.62) FABP3TERTPTPN1PPARGPPARD
Water SCHEMBL3915280 0.96 FABP3 (0.62) FABP3TERTPTPN1PPARGPPARD
Bromide SCHEMBL3414482 0.96 FABP3 (0.62) FABP3TERTPTPN1PPARGPPARD
Hydrochloric Acid SCHEMBL35815 0.96 FABP3 (0.62) FABP3TERTPTPN1PPARGPPARD
Hydrochloric Acid SCHEMBL25963 0.96 FABP3 (0.62) FABP3TERTPTPN1PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103619325-A Methods for producing liposomes STATENS SERUMINSTITUT 2014-03-05 CN claimed
CN-1980638-B Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids STATENS SERUMINSTITUT 2011-10-12 CN claimed
US-20210113466-A1 NON-VIRAL, NON-CATIONIC NANOPARTICLES AND USES THEREOF CHILDREN'S MEDICAL CENTER CORPORATION (US) 2021-04-22 US disclosed
WO-2018170414-A1 NON-VIRAL, NON-CATIONIC NANOPARTICLES AND USES THEREOF CHILDREN'S MEDICAL CENTER CORPORATION (US) 2018-09-20 WO disclosed
WO-2017220099-A1 ADJUVANTS WITH MODIFIED DRAINAGE PROPERTIES STATENS SERUM INSTITUT (DK) 2017-12-28 WO disclosed
EP-2411515-B1 USE OF MICRORNA-199B-5P IN MEDICAL AND DIAGNOSTIC FIELD ADVANCED ACCELERATOR APPLICATIONS S A (FR) 2017-01-11 EP disclosed
US-9017938-B2 Use of microrna-199b-5p in medical and diagnostic field ADVANCED ACCELERATOR APPLICATIONS (FR) 2015-04-28 US disclosed
CN-103619325-A Methods for producing liposomes STATENS SERUMINSTITUT 2014-03-05 CN disclosed
CN-101790384-B Use of mono-branched acylglycerols (MMG) as adjuvants STATENS SERUMINSTITUT 2013-12-11 CN disclosed
US-20120108656-A1 USE OF MICRORNA-199B-5P IN MEDICAL AND DIAGNOSTIC FIELD ADVANCED ACCELERATOR APPLICATIONS (FR) 2012-05-03 US disclosed
EP-2411515-A1 USE OF MICRORNA-199B-5P IN MEDICAL AND DIAGNOSTIC FIELD Advanced Accelerator Applications (FR) 2012-02-01 EP disclosed
CN-1980638-B Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids STATENS SERUMINSTITUT 2011-10-12 CN disclosed
WO-2010109511-A1 USE OF MICRORNA-199B-5P IN MEDICAL AND DIAGNOSTIC FIELD ZOLLO MASSIMO (IT) 2010-09-30 WO disclosed
CN-101790384-A Use of mono-branched acylglycerols (MMG) as adjuvants STATENS SERUMINSTITUT 2010-07-28 CN disclosed
CN-1980638-A Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids STATENS SERUMINSTITUT (DK) 2007-06-13 CN disclosed